← Evidence map

ArticleFrontiers in genetics2026

When genomics companies act as biobanks: governance challenges in an era of genomic assetization.

Alexis WalkerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41890229